Title: Strategic Planning Clinical Programs
1Strategic Planning Clinical Programs
- School of Medicine Retreat January 30, 2003
2Mission Statement
"We promote the health of our patients and our
community and advance the frontiers of clinical
medicine"
3Context- Key Financial Accomplishments of FY 2002
- Further stabilization of Stanford Hospital's
operating margin, ie first positive operating
margin since merger - Improvement in practice's clinical revenues (91m
to 108m) and profits (16.8m) - Assessment, with SHC, of capital needs of SHC and
of our practice - plans for raising 250m in bond market to
achieve it - Consensus-building in funds flow methodologies
regarding payments from Hospital to School for
services rendered
4Context
Clinical Practice Revenue
5Context
Direct Research Expenditures
6Context
Clinical Departments Revenues
7Ambulatory Growth
- Ambulatory services are growing and becoming an
increasing fraction of SHC's revenue streams, now
accounting for 40 of SHC charges and 55 of
faculty charges - 57 of faculty collections were derived from
outpatient svcs in FY'02 - The increasing importance of ambulatory services
revenue means that both the faculty and SHC are
increasingly dependent on its growth for economic
viability, as well as for a secure referral base - Neither can afford to concede wholly the profit
derived from outpatient services to the other
entity
8 Exclusion of LSS (Pediatric based) data for
FY2000 and FY2001 Exclusion of Capitation
reimbursement for all fiscal years.
9Key Issues in Ambulatory Services
- Funds flow in ambulatory services must incent
growth - Revenues from newer infused therapies and
diagnostics need to be shared between SHC and the
faculty to encourage development - Attribution of expense to ambulatory services,
but not to inpatient services, means largely
ambulatory services are being neglected as sites
for growth - Newer treatment options for common chronic
diseases (immune modulators, etc) tend to be
outpatient modalities - With the recruitment of a new VP for Ambulatory
Services, along with service and operational
issues, funds flow issues must be addressed
10Patient Base
A Strategic Imperative Defining and controlling
our access to the patient base around us
- Kaiser controls 40 of the patient base around
us and is seeking to do its own
tertiary/quaternary care - Sutter/PAMF accounts for 23 of SHC discharges
now and is seeking to consolidate the large
majority of the remaining non-Kaiser patients
into their system - Stanford needs access to patients who will
benefit from our care and help us advance medical
knowledge
11Patient Base
Potential Strategies for Maintaining Patient
Access
- Create a full service health system
- Partner with full service systems
- Be the quality and value leader
- superior skill sets, knowledge bases, but also
excellent service - cost basis that is attractive to full service
systems and their constituencies
12Unresolved Issues in Potential Satellite
Facilities
- Should a satellite facility be ambulatory,
inpatient, "short stay", specialty-specific? - If we had a partner, multiple issues would arise
- Business model is complex in governance and
calculations - Medical group representation also is complex
- Current reality is that partnering with Sutter
remains uncertain, and we need to have an
independent strategy
13Quality and Value Leadership
- Stanford still enjoys public stature as a quality
leader - PacifiCare quality index just released placed us
at 95th of 200 California hospitals, and the
highest among academic hospitals - UCSF scored at 78th, UCLA at 58th in 60 metrics
related to common practices - UC Davis scored only at 44th
- Patient satisfaction scores in ambulatory
services have recently been below historical
norms - Third party payers are now introducing "tiering",
a designation made by insurers to establish
different payments to centers, based on "quality
and cost" - Aetna and Blue Cross propose us as first tier
designees, but Healthnet seeks to place us in
second tier
14Applied Research
- Current models
- BMTx Unit
- Oncology Clinic
- Stroke Service
- Device Development Center
- Imaging Services
- Potential models
- Stanford Cancer Institute
- Stanford Neurosciences Institute
- Stanford Cardiovascular Medicine Institute
15Newer Initiatives- Clinical Centers
- Multidisciplinary clinical centers of excellence
are increasingly the norm across the US because
patients want them - Centers will have multidisciplinary governance,
administrative infrastructure, and may be nested
in Institutes, which can serve as the focused
research sites from which translational
initiatives might arise - Centers are planned in cardiovascular,
neurological, cancer and transplantation services - Centers can help us engage the public and its
philanthropy, enlarge our reputation as industry
leaders, and be the platform for development of
novel strategies, ie be the "critical mass" that
smaller subunits will never achieve
16Institutes Scope
Stanford Institutes of Medicine
Research
Patient Care
Institute for Cancer/Stem Cell Biology and
Medicine
Future Institute
Future Institute
Future Institute
Future Institute
17Institute Organization
Institute for Cancer/Stem Cell Biology and
Medicine
Research Center
Clinical Cancer Center
Clinical Informatics
ACCESS/SPTRC
GCRC
Breast Cancer Center
Prostate Cancer Center
Basic Research
Clinical Research
Head Neck Cancer Center
Institute-Based Associates
Leukemia Center
????? Cancer Center
Department-Based Affiliates
Radiation Therapy
Surgical Oncology
Translational Research Core Facilities
Bone Marrow Transplantation
18Faculty Practice Organization
- Fundamental issues in FPO
- Does it represent and is it composed of faculty
at large or chairs? - Is it an organization embedded in the Hospital or
to the School? - Is it a "group practice" with a strong central
authority or a confederation of departments? - What should it govern and control?
19Practice Organization
- Dean and CEO agreed in 8/02 upon structure that
recognized a confederation of depts as the
fundamental organizational model - Council of Clinical Chairs provides forum for
input and deliberation about issues surrounding
professional practice - Dean, CEO, Clinical Chairs, COO, CFO and Sr Deans
for Clinical Affairs and Finance and
Administration - Meets biweekly, chaired by Sr Dean for Clinical
Affairs and COO - Smaller Joint Clinical Planning Committee creates
proposals, organizes initiatives and supervises
strategic planning - Dean, CEO, COO, CFO, Sr Deans for Clinical
Affairs and Finance and Administration - Meets at least weekly or more frequently when
needed
20Current Organizational Chart
Dean and CEO
CEO
Council of Clinical Chairs
Joint Clinical Planning Committee
Dean SAD Clin Affairs SAD FA
CEO COO CFO
Professional Contracts
Professional Billing (PFS)
Ambulatory Services
QA / Compliance
Adult/Children's Services Carve-out Splits
21Goals for 2003
- Refine and begin to implement strategy for
securing our patient base, by creating off-site
ambulatory services, if possible with a
partnership with a full service health care
system - Refine and enlarge the initiative for institute
and center development, as platform for clinical
growth and translation - Develop further the practice's organizational
structure and funds flow to align finances and
mission-based goals
22Key Challenges
- Availability of timely, accurate data relating to
financial performance across the hospital and the
faculty practice - Volume, expense and profitability of clinical
units - PL, expenses and performance should be
transparent - Development of a faculty culture that seeks to
enlarge the enterprise's resources, rather than
seeking advantage in re-negotiating different
splits of it - Centers and institutes will require re-shuffling
of some authorities, accountabilities and funds
flows
23Key Challenges
- Advocacy for and recognition of the value of
providers of clinical care and education - enable us to recruit and retain physicians in the
"physician-educator line" - Better communication between UTL and MCL lines
for translational initiatives